Main findings
For the first time, we have demonstrated that reduced maternal
gestational pulmonary function, assessed by moderate-to-severe
reductions in baseline FEV1% predicted is a significant
predictor of fetal death. There was no significant association between
low maternal FEV1% predicted and adverse maternal
outcomes including ACS, acute painful episodes and maternal deaths.